Real-time enrollment status for this heart failure clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 11:02 PM UTC
| NCT Number | NCT06677060 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure |
| Phase | PHASE3 |
| Target Enrollment | 11,300 participants |
| Active Locations | 198 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 15, 2026 (Sep 15, 2026) |
As of October 17, 2026: Clinical trial NCT06677060 is currently recruiting participants. This phase3 study for heart failure is actively seeking new participants at 198 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06677060 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 198 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06677060 was last updated Sep 15, 2026 (September 15, 2026). HelloStudys verifies this status automatically.